Literature DB >> 27189946

Type II Turn of Receptor-bound Salmon Calcitonin Revealed by X-ray Crystallography.

Eva Johansson1, Jakob Lerche Hansen2, Ann Maria Kruse Hansen2, Allan Christian Shaw2, Peter Becker2, Lauge Schäffer2, Steffen Reedtz-Runge2.   

Abstract

Calcitonin is a peptide hormone consisting of 32 amino acid residues and the calcitonin receptor is a Class B G protein-coupled receptor (GPCR). The crystal structure of the human calcitonin receptor ectodomain (CTR ECD) in complex with a truncated analogue of salmon calcitonin ([BrPhe(22)]sCT(8-32)) has been determined to 2.1-Å resolution. Parallel analysis of a series of peptide ligands showed that the rank order of binding of the CTR ECD is identical to the rank order of binding of the full-length CTR, confirming the structural integrity and relevance of the isolated CTR ECD. The structure of the CTR ECD is similar to other Class B GPCRs and the ligand binding site is similar to the binding site of the homologous receptors for the calcitonin gene-related peptide (CGRP) and adrenomedulin (AM) recently published (Booe, J. M., Walker, C. S., Barwell, J., Kuteyi, G., Simms, J., Jamaluddin, M. A., Warner, M. L., Bill, R. M., Harris, P. W., Brimble, M. A., Poyner, D. R., Hay, D. L., and Pioszak, A. A. (2015) Mol. Cell 58, 1040-1052). Interestingly the receptor-bound structure of the ligand [BrPhe(22)]sCT(8-32) differs from the receptor-bound structure of the homologous ligands CGRP and AM. They all adopt an extended conformation followed by a C-terminal β turn, however, [BrPhe(22)]sCT(8-32) adopts a type II turn (Gly(28)-Thr(31)), whereas CGRP and AM adopt type I turns. Our results suggest that a type II turn is the preferred conformation of calcitonin, whereas a type I turn is the preferred conformation of peptides that require RAMPs; CGRP, AM, and amylin. In addition the structure provides a detailed molecular explanation and hypothesis regarding ligand binding properties of CTR and the amylin receptors.
© 2016 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  G protein-coupled receptor (GPCR); amylin; calcitonin; crystal structure; peptide conformation; peptide hormone; peptide interaction

Mesh:

Substances:

Year:  2016        PMID: 27189946      PMCID: PMC4919452          DOI: 10.1074/jbc.M116.726034

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  37 in total

Review 1.  International Union of Pharmacology. XXXII. The mammalian calcitonin gene-related peptides, adrenomedullin, amylin, and calcitonin receptors.

Authors:  David R Poyner; Patrick M Sexton; Ian Marshall; David M Smith; Remi Quirion; Walter Born; Roman Muff; Jan A Fischer; Steven M Foord
Journal:  Pharmacol Rev       Date:  2002-06       Impact factor: 25.468

2.  Evidence for calcitonin--a new hormone from the parathyroid that lowers blood calcium.

Authors:  D H COPP; E C CAMERON; B A CHENEY; A G DAVIDSON; K G HENZE
Journal:  Endocrinology       Date:  1962-05       Impact factor: 4.736

3.  Molecular approximation between a residue in the amino-terminal region of calcitonin and the third extracellular loop of the class B G protein-coupled calcitonin receptor.

Authors:  Maoqing Dong; Delia I Pinon; Richard F Cox; Laurence J Miller
Journal:  J Biol Chem       Date:  2004-05-20       Impact factor: 5.157

Review 4.  Calcitonin.

Authors:  David M Findlay; Patrick M Sexton
Journal:  Growth Factors       Date:  2004-12       Impact factor: 2.511

Review 5.  Mechanisms of peptide and nonpeptide ligand binding to Class B G-protein-coupled receptors.

Authors:  Sam R J Hoare
Journal:  Drug Discov Today       Date:  2005-03-15       Impact factor: 7.851

6.  Amylin receptor phenotypes derived from human calcitonin receptor/RAMP coexpression exhibit pharmacological differences dependent on receptor isoform and host cell environment.

Authors:  N Tilakaratne; G Christopoulos; E T Zumpe; S M Foord; P M Sexton
Journal:  J Pharmacol Exp Ther       Date:  2000-07       Impact factor: 4.030

7.  Multiple amylin receptors arise from receptor activity-modifying protein interaction with the calcitonin receptor gene product.

Authors:  G Christopoulos; K J Perry; M Morfis; N Tilakaratne; Y Gao; N J Fraser; M J Main; S M Foord; P M Sexton
Journal:  Mol Pharmacol       Date:  1999-07       Impact factor: 4.436

8.  An amylin receptor is revealed following co-transfection of a calcitonin receptor with receptor activity modifying proteins-1 or -3.

Authors:  R Muff; N Bühlmann; J A Fischer; W Born
Journal:  Endocrinology       Date:  1999-06       Impact factor: 4.736

9.  Spatial proximity between a photolabile residue in position 19 of salmon calcitonin and the amino terminus of the human calcitonin receptor.

Authors:  Vi Pham; John D Wade; Brooke W Purdue; Patrick M Sexton
Journal:  J Biol Chem       Date:  2003-11-17       Impact factor: 5.157

10.  Importance of the amino terminus in secretin family G protein-coupled receptors. Intrinsic photoaffinity labeling establishes initial docking constraints for the calcitonin receptor.

Authors:  Maoqing Dong; Delia I Pinon; Richard F Cox; Laurence J Miller
Journal:  J Biol Chem       Date:  2003-10-28       Impact factor: 5.157

View more
  12 in total

1.  N-Glycosylation of Asparagine 130 in the Extracellular Domain of the Human Calcitonin Receptor Significantly Increases Peptide Hormone Affinity.

Authors:  Sang-Min Lee; Jason M Booe; Joseph J Gingell; Virginie Sjoelund; Debbie L Hay; Augen A Pioszak
Journal:  Biochemistry       Date:  2017-06-26       Impact factor: 3.162

Review 2.  Update on the pharmacology of calcitonin/CGRP family of peptides: IUPHAR Review 25.

Authors:  Debbie L Hay; Michael L Garelja; David R Poyner; Christopher S Walker
Journal:  Br J Pharmacol       Date:  2017-11-28       Impact factor: 8.739

3.  Calcitonin Receptor N-Glycosylation Enhances Peptide Hormone Affinity by Controlling Receptor Dynamics.

Authors:  Sang-Min Lee; Yejin Jeong; John Simms; Margaret L Warner; David R Poyner; Ka Young Chung; Augen A Pioszak
Journal:  J Mol Biol       Date:  2020-02-06       Impact factor: 5.469

Review 4.  Advances in therapeutic peptides targeting G protein-coupled receptors.

Authors:  Anthony P Davenport; Conor C G Scully; Chris de Graaf; Alastair J H Brown; Janet J Maguire
Journal:  Nat Rev Drug Discov       Date:  2020-03-19       Impact factor: 84.694

5.  Molecular interaction of an antagonistic amylin analog with the extracellular domain of receptor activity-modifying protein 2 assessed by fluorescence polarization.

Authors:  Sangmin Lee; Augen A Pioszak
Journal:  Biophys Chem       Date:  2020-09-20       Impact factor: 2.352

Review 6.  Recent Advances in Pharmacotherapy for Migraine Prevention: From Pathophysiology to New Drugs.

Authors:  Jonathan Jia Yuan Ong; Diana Yi-Ting Wei; Peter J Goadsby
Journal:  Drugs       Date:  2018-03       Impact factor: 9.546

Review 7.  RAMPs as allosteric modulators of the calcitonin and calcitonin-like class B G protein-coupled receptors.

Authors:  Augen A Pioszak; Debbie L Hay
Journal:  Adv Pharmacol       Date:  2020-01-27

8.  Molecular Signature for Receptor Engagement in the Metabolic Peptide Hormone Amylin.

Authors:  Rebekah L Bower; Lauren Yule; Tayla A Rees; Giuseppe Deganutti; Erica R Hendrikse; Paul W R Harris; Renata Kowalczyk; Zachary Ridgway; Amy G Wong; Katarzyna Swierkula; Daniel P Raleigh; Augen A Pioszak; Margaret A Brimble; Christopher A Reynolds; Christopher S Walker; Debbie L Hay
Journal:  ACS Pharmacol Transl Sci       Date:  2018-04-23

9.  Phase-plate cryo-EM structure of a class B GPCR-G-protein complex.

Authors:  Yi-Lynn Liang; Maryam Khoshouei; Mazdak Radjainia; Yan Zhang; Alisa Glukhova; Jeffrey Tarrasch; David M Thal; Sebastian G B Furness; George Christopoulos; Thomas Coudrat; Radostin Danev; Wolfgang Baumeister; Laurence J Miller; Arthur Christopoulos; Brian K Kobilka; Denise Wootten; Georgios Skiniotis; Patrick M Sexton
Journal:  Nature       Date:  2017-04-24       Impact factor: 49.962

10.  Extracellular loops 2 and 3 of the calcitonin receptor selectively modify agonist binding and efficacy.

Authors:  Emma Dal Maso; Yue Zhu; Vi Pham; Christopher A Reynolds; Giuseppe Deganutti; Caroline A Hick; Dehua Yang; Arthur Christopoulos; Debbie L Hay; Ming-Wei Wang; Patrick M Sexton; Sebastian G B Furness; Denise Wootten
Journal:  Biochem Pharmacol       Date:  2018-02-16       Impact factor: 5.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.